Cite
HARVARD Citation
Spring, L. et al. (2021). Sacituzumab Govitecan for Metastatic Triple‐Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities. Oncologist. pp. 827-834. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Spring, L. et al. (2021). Sacituzumab Govitecan for Metastatic Triple‐Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities. Oncologist. pp. 827-834. [Online].